Cellular-level versus receptor-level response threshold hierarchies in T-cell activation

Frontiers in Immunology

Volumn 4, Issue SEP, 2013, Pages

  van den Berg, Hugo A ^a   Ladell, Kristin ^b   Miners, Kelly ^b   Laugel, Bruno ^b   Llewellyn Lacey, Sian ^b   Clement, Mathew ^b   Cole, David K ^b   Gostick, Emma ^b   Wooldridge, Linda ^b   Sewell, Andrew K ^b   Bridgeman, John S ^b   Price, David A ^b,c  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

T cell activation; T cell cross reactivity; T cell receptor

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOASSAY; DISSOCIATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; T LYMPHOCYTE ACTIVATION; THEORY;

EID: 84886057612     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00250     Document Type: Article

References (68)

1. Parham P. The Immune System. New York: Garland Publishing (2000).
2. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol (2006) 24:419-66. doi:10.1146/annurev.immunol.23.021704.115658.
3. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today (1998) 19: 395-404. doi:10.1016/S0167-5699(98)01299-7.
4. Wraith DC, Bruun B, Fairchild PJ. Cross-reactive antigen recognition by an encephalitogenetic T cell receptor. J Immunol (1992) 149:3765-70.
5. Bhardwaj V, Kumar V, Geysen HM, Sercarz EE. Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein. Implications for thymic education and autoimmunity. J Immunol (1993) 151:5000-10.
6. Reay PA, Kantor RM, Davis MM. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J Immunol (1994) 152:3946-3957.
7. Evavold BD, Sloan-Lancaster J, Wilson KJ, Rothbard JB, Allen PM. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity (1995) 2: 655-63. doi:10.1016/1074-7613(95)90010-1.
8. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell (1995) 80: 695-705. doi:10.1016/0092-8674(95)90348-8.
9. Ignatowicz L, Rees W, Pacholczyk R, Ignatowicz H, Kushnir E, Kappler J, et al. T cells can be activated by peptides that are unrelated in sequence to their selecting peptide. Immunity (1997) 7: 179-186. doi:10.1016/S1074-7613(00)80521-X.
10. Hemmer B, Fleckenstein BT, Vergelli M, Jung G, McFarland H, Martin R, et al. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med (1997) 185:1651-1659. doi:10.1084/jem.185.9.1651.
11. Bachmann MF, Speiser DE, Zakarian A, Ohashi PS. Inhibition of TCR triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR antagonism. Eur J Immunol (1998) 28:3110-9. doi:10.1002/(SICI)1521-4141(199810)28:10<3110::AID-IMMU3110>3.0.CO;2-5.
12. Wilson DB, Wilson DH, Schroder K, Pinilla C, Blondelle S, Houghten RA, et al. Specificity and degeneracy of T cells. Mol Immunol (2004) 40:1047-1055. doi:10.1016/j.molimm.2003.11.022.
13. Ishizuka J, Grebe K, Shenderov E, Peters B, Chen Q, Peng Y, et al. Quantitating T cell cross-reactivity for unrelated peptide antigens. J Immunol (2009) 183:4337-45. doi:10.4049/jimmunol.0901607.
14. Wooldridge L, Ekeruche-Makinde J, van den Berg HA, Skowera A, Miles JJ, Tan MP, et al. A single autoimmune T cell receptor recognizes more than a million different peptides. J Biol Chem (2012) 287:1168-77. doi:10.1074/jbc. M111.289488.
15. Valitutti S, Müller S, Dessing M, Lanzavecchia A. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J Exp Med (1996) 183:1917-1921. doi:10.1084/jem.183.4.1917.
16. Itoh Y, Germain RN. Single cell analysis reveals regulated hierarchical T cell antigen receptor signaling thresholds and intraclonal heterogeneity for individual cytokine responses of CD4+ cells. J Exp Med (1997) 186:757-766. doi:10.1084/jem.186.5.757.
17. Hemmer B, Stefanova I, Vergelli M, Germain RN, Martin R. Relationships among TCR ligand potency, thresholds for effector function elicitation, and the quality of early signaling events in human T cells. J Immunol (1998) 160:5807-5814.
18. Price DA, Sewell AK, Dong T, Tan R, Goulder PJR, Rowland-Jones SL, et al. Antigen-specific release of β-chemokines by anti-HIV-1 cytotoxic T lymphocytes. Curr Biol (1998) 8:355-8. doi:10.1016/S0960-9822(98)70138-1.
19. Rabinowitz JD, Beeson C, Lyons DS, Davis MM, McConnell HM. Kinetic discrimination in T-cell activation. Proc Natl Acad Sci U S A (1996) 93:1401-1405. doi:10.1073/pnas.93.4.1401.
20. McKeithan TW. Kinetic proofreading in T-cell receptor signal transduction. Proc Natl Acad Sci U S A (1995) 92:5042-5046. doi:10.1073/pnas.92.11.5042.
21. Lanzavecchia A, Iezzi G, Viola A. From TCR engagement to T cell activation: a kinetic view of T cell behavior. Cell (1999) 96:1-4. doi:10.1016/S0092-8674(00)80952-6.
22. van den Berg HA, Rand DA, Burroughs NJ. A reliable and safe T cell repertoire based on low-affinity T cell receptors. J Theor Biol (2001) 209:465-486. doi:10.1006/jtbi.2001.2281.
23. van den Berg HA, Burroughs NJ, Rand DA. Quantifying the strength of ligand antagonism in TCR triggering. Bull Math Biol (2002) 64:781-808. doi:10.1006/bulm.2002.0302.
24. Bridgeman JS, Sewell AK, Miles JJ, Price DA, Cole DK. Structural and biophysical determinants of aβ T-cell antigen recognition. Immunology (2012) 135:9-18. doi:10.1111/j.1365-2567.2011.03515.x.
25. van den Berg HA, Rand DA. Quantitative theories of T-cell responsiveness. Immunol Rev (2007) 216:81-92. doi:10.1111/j.1600-065X.2006.00491.x.
26. Irving M, Zoete V, Hebeisen M, Schmid D, Baumgartner P, Guillaume P, et al. Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness. J Biol Chem (2012) 287:23068-78. doi:10.1074/jbc. M112.357673.
27. Laugel B, van den Berg HA, Gostick E, Cole DK, Wooldridge L, Boulter J, et al. Different T cell receptor affinity thresholds and CD8 coreceptor dependency govern cytotoxic T lymphocyte activation and tetramer binding properties. J Biol Chem (2007) 282:23799-810. doi:10.1074/jbc. M700976200.
28. Melenhorst JJ, Scheinberg P, Chattopadhyay PK, Lissina A, Gostick E, Cole DK, et al. Detection of low avidity CD8+ T cell populations with coreceptor-enhanced peptide-major histocompatibility complex class I tetramers. J Immunol Methods (2008) 338:31-9. doi:10.1016/j.jim.2008.07.008.
29. Wooldridge L, Laugel B, Ekeruche J, Clement M, van den Berg HA, Price DA, et al. CD8 controls T cell cross-reactivity. J Immunol (2010) 185:4625-32. doi:10.4049/jimmunol.1001480.
30. Purbhoo MA, Boulter JM, Price DA, Vuidepot A-L, Hourigan CS, Dunbar PR, et al. The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor ? chain. J Biol Chem (2001) 276:32786-32792. doi:10.1074/jbc. M102498200.
31. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M, et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods (2003) 281:65-78. doi:10.1016/S0022-1759(03)00265-5.
32. Cole DK, Pumphrey NJ, Boulter JM, Sami M, Bell JI, Gostick E, et al. Human TCR-binding affinity is governed by MHC class restriction. J Immunol (2007) 178:5727-34.
33. Cole DK, Yuan F, Rizkallah PJ, Miles JJ, Gostick E, Price DA, et al. Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor. J Biol Chem (2009) 284:27281-9. doi:10.1074/jbc. M109.022509.
34. Cole DK, Rizkallah PJ, Boulter JM, Sami M, Vuidepot A, Glick M, et al. Computational design and crystal structure of an enhanced-affinity mutant human CD8 aa coreceptor. Proteins (2007) 67:65-74. doi:10.1002/prot.21176.
35. Valitutti S, Müller S, Cella M, Padovan E, Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature (1995) 375:148-151. doi:10.1038/375148a0.
36. Valitutti S, Lanzavecchia A. Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition. Immunol Today (1997) 18:299-304. doi:10.1016/S0167-5699(97)80027-8.
37. Valitutti S. The serial engagement model 17 years after: from TCR triggering to immunotherapy. Front Immunol (2012) 3:272. doi:10.3389/fimmu.2012.00272.
38. Wooldridge L, van den Berg HA, Glick M, Gostick E, Brenchley JM, Douek DC, et al. Interaction between the CD8 coreceptor and MHC class I stabilizes TCR-antigen complexes at the cell surface. J Biol Chem (2005) 280:27491-27501. doi:10.1074/jbc. M500555200.
39. van den Berg HA, Wooldridge L, Laugel B, Sewell AK. Coreceptor CD8-driven modulation of T cell antigen receptor specificity. J Theor Biol (2007) 249:395-408. doi:10.1016/j.jtbi.2007.08.002.
40. Luescher IF, Vivier E, Layer A, Mahiou J, Godeau F, Malissen B, et al. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature (1995) 373:353-356. doi:10.1038/373353a0.
41. Gonzales PA, Carreño LJ, Coombs D, Mora JE, Palmeiri E, Goldstein B, et al. T cell receptor binding kinetics required for T cell activation depend on the density of the cognate ligand of the antigen-presenting cell. Proc Natl Acad Sci U S A (2005) 102:4824-4829. doi:10.1073/pnas.0500922102.
42. Kalergis AM, Boucheron N, Doucey M-A, Palmieri E, Goyarts EC, Vegh Z, et al. Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex. Nat Immunol (2001) 2:229-34. doi:10.1038/85286.
43. Holler PD, Lim AR, Cho BK, Rund LA, Kranz DM. CD8-T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation. J Exp Med (2001) 194:1043-1052. doi:10.1084/jem.194.8.1043.
44. Carreño LJ, González PA, Kalergis AM. Modulation of T cell function by TCR/pMHC binding kinetics. Immunobiology (2006) 211:47-64. doi:10.1016/j.imbio.2005.09.003.
45. Govern CC, Paczosa MK, Chakraborty AK, Huseby ES. Fast on-rates allow short dwell time ligands to activate T cells. Proc Natl Acad Sci U S A (2010) 107:8724-9. doi:10.1073/pnas.1000966107.
46. Dushek O, Aleksic M, Wheeler RJ, Zhang H, Cordoba S-P, Peng Y-C, et al. Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation. Sci Signal (2011) 4:ra39. doi:10.1126/scisignal.2001430.
47. Arcaro A, Grégoire C, Bakker TR, Baldi L, Jordan M, Goffin L, et al. CD8β endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56lck complexes. J Exp Med (2001) 194:1485-95. doi:10.1084/jem.194.10.1485.
48. Bosselut R, Kubo S, Guinter T, Kopacz JL, Altman JD, Feigenbaum L, et al. Role of CD8β domains in CD8 coreceptor function: importance for MHC I binding, signaling, and positive selection of CD8+ T cells in the thymus. Immunity (2000) 12:409-418. doi:10.1016/S1074-7613(00)80193-4.
49. Gangadharan D, Cheroute H. The CD8 isoform CD8aa is not a functional homologue of the TCR co-receptor CD8aβ. Curr Opin Immunol (2004) 16:264-270. doi:10.1016/j.coi.2004.03.015.
50. Arcaro A, Grégoire C, Boucheron N, Stolz S, Palmer E, Malissen B, et al. Essential role of CD8 palmitoylation in CD8 coreceptor function. J Immunol (2000) 165:2068-2076.
51. Laugel B, Cole DK, Clement M, Wooldridge L, Price DA, Sewell AK. The multiple roles of the CD8 coreceptor in T cell biology: opportunities for the selective modulation of self-reactive cytotoxic T cells. J Leukoc Biol (2011) 90:1089-99. doi:10.1189/jlb.0611316.
52. van den Berg HA, Sewell AK. Dynamic tuning of T cell receptor specificity by co-receptors and costimulation. In: Molina-París C, Lythe G, editors. Mathematical Models and Immune Cell Biology. Berlin: Springer-Verlag (2011) pp. 47-73.
53. Mukhopadhyay H, Cordoba S-P, Maini PK, van der Merwe PA, Dushek O. Systems model of T cell receptor proximal signaling reveals emergent ultrasensitivity. PLoS Comput Biol (2013) 9:e1003004. doi:10.1371/journal.pcbi.1003004.
54. Wu Y, Vendome J, Shapiro L, Ben-Shaul A, Honig B. Transforming binding affinities from three dimensions to two with application to cadherin clustering. Nature (2011) 475:510-4. doi:10.1038/nature10183.
55. Zarnitsyna V, Zhu C. T cell triggering: insights from 2D kinetics analysis of molecular interactions. Phys Biol (2012) 9:045005. doi:10.1088/1478-3975/9/4/045005.
56. Bell GI. Models for the specific adhesion of cells to cells. Science (1978) 200:618-27. doi:10.1126/science.347575.
57. Bell GI, Dembo M, Bongrand P. Cell adhesion. Competition between nonspecific repulsion and specific bonding. Biophys J (1984) 45:1051-64. doi:10.1016/S0006-3495(84)84252-6.
58. Werlen G, Palmer E. The TCR signalosome: a dynamic structure with expanding complexity. Curr Opin Immunol (2002) 14:299-305. doi:10.1016/S0952-7915(02)00339-4.
59. Filipp D, Zhang J, Leung BL, Shaw A, Levin SD, Veillette A, et al. Regulation of Fyn through translocation of activated Lck into lipid rafts. J Exp Med (2003) 197:1221-1227. doi:10.1084/jem.20022112.
60. Maile R, Siler CA, Kerry SE, MidkiffKE, Collins EJ, Frelinger JA. Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo. J Immunol (2005) 174:619-627.
61. Park J-H, Adoro S, Lucas PJ, Sarafova SD, Alag AS, Doan LL, et al. 'Coreceptor tuning': cytokine signals transcriptionally tailor CD8 coreceptor expression to the self-specificity of the TCR. Nat Immunol (2007) 8:1049-58. doi:10.1038/ni1512.
62. Collins AV, Brodie DW, Gilbert RJC, Iaboni A, Manso-Sancho R, Stuart DI, et al. The interaction properties of costimulatory molecules revisited. Immunity (2002) 17:201-10. doi:10.1016/S1074-7613(02)00362-X.
63. Grossman Z, Paul WE. Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses. Proc Natl Acad Sci U S A (1992) 89:10365-10369. doi:10.1073/pnas.89.21.10365.
64. van den Berg HA, Rand DA. Dynamics of T cell activation threshold tuning. J Theor Biol (2004) 228:397-416. doi:10.1016/j.jtbi.2004.02.002.
65. Aleksic M, Dushek O, Zhang H, Shenderov E, Chen J-L, Cerundolo V, et al. Dependence of the T cell antigen receptor on the T cell receptor-peptide MHC confinement time. Immunity (2010) 32:1-12. doi:10.1016/j.immuni.2009.11.013.
66. Lauritsen JPH, Christensen MD, Dietrich J, Kastrup J, Ødum N, Geisler C. Two distinct pathways exist for down-regulation of the TCR. J Immunol (1998) 161:260-267.
67. Liu H, Rhodes M, Wiest DL, Vignali DAA. On the dynamics of TCR:CD3 complex cell surface expression and downmodulation. Immunity (2000) 13:665-675. doi:10.1016/S1074-7613(00)00066-2.
68. Sousa J, Carneiro J. A mathematical analysis of TCR serial triggering and down-regulation. Eur J Immunol (2000) 30:3219-3227. doi:10.1002/1521-4141(200011)30:11<3219::AID-IMMU3219>3.0.CO;2-7.